Registered Rwanda · Rwanda FDA

Lidocaine & Adrenaline Injection BP (21.33 mg + 0.0125 mg/ml)

-

RWANDA-FDA25/HM/0385/0012 Solution for Injection. Lidocaine Hydrochloride BP 21.33 mg/ml & Adrenaline Acid Tartrate Eq. to Adrenaline BP 0.0125 mg/ml

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
RWANDA-FDA25/HM/0385/0012
Registration date
05/02/2026
Expiry date
04/02/2031
Status
Registered
Active ingredient
-
Dosage form
Solution for Injection.
Strength
Lidocaine Hydrochloride BP 21.33 mg/ml & Adrenaline Acid Tartrate Eq. to Adrenaline BP 0.0125 mg/ml
Pack size
30ml
Therapeutic class
-
Manufacturer / MAH
Swati Spentose
Applicant / LTR
Lincoln Pharmaceuticals Limited
Country of origin
India
Manufacturer location
Plot No. A1/2102 &, 2103, A-1, 2, Industrial Area Rd, Phase 3, GIDC, Vapi, Gujarat 396195, India

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:02 · updated 2026-09-21 02:30:18

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.